Cited by 161Liver Diseases and ImmunityLiver physiology and pathologyTelomeres, Telomerase, and Senescence

Paracrine cellular senescence exacerbates biliary injury and impairs regeneration

Open access
Ferreira-Gonzalez, Sofia, Lu, Wei-Yu, Raven, Alexander, Dwyer, Benjamin, Man, Tak Yung, O’Duibhir, Eoghan, Lewis, Philip J. Starkey, Campana, Lara +6 more·2018·Nature Communications

Abstract

Cellular senescence is a mechanism that provides an irreversible barrier to cell cycle progression to prevent undesired proliferation. However, under pathological circumstances, senescence can adversely affect organ function, viability and regeneration. We have developed a mouse model of biliary senescence, based on the conditional deletion of Mdm2 in bile ducts under the control of the Krt19 promoter, that exhibits features of biliary disease. Here we report that senescent cholangiocytes induce profound alterations in the cellular and signalling microenvironment, with recruitment of myofibroblasts and macrophages causing collagen deposition, TGFβ production and induction of senescence in surrounding cholangiocytes and hepatocytes. Finally, we study how inhibition of TGFβ-signalling disrupts the transmission of senescence and restores liver function. We identify cellular senescence as a detrimental mechanism in the development of biliary injury. Our results identify TGFβ as a potential therapeutic target to limit senescence-dependent aggravation in human cholangiopathies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-03299-5

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TGF-β1 inhibition attenuates liver fibrosis in a biliary senescence model.

    “In contrast, TGF-β1 inhibition attenuated liver fibrosis in a biliary senescence model (127), underscoring the strong context dependence of its effects.”

    From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [127]

    The Results section (‘Inhibition of TGFβ in vivo improves liver function’; page unavailable) reports decreased collagen deposition after treatment with a TGFβR1 antagonist in the biliary senescence model. It says this may reflect a reduced fibrogenic response, rather than establishing that liver fibrosis was attenuated. The intervention inhibited TGFβ receptor signaling, not TGF-β1 specifically. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • In aged organisms, senescent cells can contribute to a variety of age-related pathologies, including pulmonary fibrosis, biliary liver damage, arteriosclerosis, retinopathy, osteoarthritis, dementia and diabetes mellitus.

    “In aged organisms, senescent cells can contribute to a variety of age- related pathologies, including pulmonary fibrosis, biliary liver damage, arteriosclerosis, retinopathy, osteoarthritis, dementia and diabetes mellitus 13-19 .”

    From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [18]

  • Cellular senescence plays crucial roles in a variety of physiological and pathological processes, including embryonic development, cancer, aging, and multiple other diseases.

    “Cellular senescence, which was initially described by Leonard Hayflick and colleagues in 1961,1 plays crucial roles in a variety of physiological and pathological processes, including embryonic development, cancer, aging, and multiple other diseases.2,3,4,5,6,7”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 51 · Cited by 161

Authors
Ferreira-Gonzalez, S., Lu, W.-Y., Raven, A., Dwyer, B., Man, T. Y., O’Duibhir, E., Lewis, P. J. S., Campana, L., Kendall, T. J., Bird, T. G., Tarrats, N., Acosta, J.-C., Boulter, L., & Forbes, S. J.
Affiliations
  • MRC Centre for Regenerative Medicine (GB)
  • Edinburgh Cancer Research (GB)
  • Institute of Genetics and Cancer (GB)
Corresponding author
Forbes, Stuart J.
Venue
Nature Communications
Published
2018-03-09
Volume
9
Issue
1
Pages
1020-1020
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2790830382
Cited by
161
References
51
Citations by year
2026: 12 · 2025: 16 · 2024: 17 · 2023: 23 · 2022: 27 · 2021: 36 · 2020: 21 · 2019: 8 · 2018: 1
FWCI
10.34
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
Funders
  • Wellcome Trust (107492/Z/15/Z)
  • Cancer Research UK (16243)
  • UK Regenerative Medicine Platform (K026666, MR/K026666/1)
  • Medical Research Council (MR/K026666, MR/P016839/1, MR/L012766/1, MR/K017047/1, MR/K026666/1)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
Keywords
cellular senescence, biliary injury, cholangiocytes, TGF-beta signaling, macrophage recruitment, collagen deposition, liver regeneration, cholangiopathy, hepatocytes
MeSH terms
Animals, Bile Ducts, Cells, Cultured, Collagen, Disease Models, Animal, Female, Humans, Liver, Liver Cirrhosis, Biliary, Macrophages, Male, Mice, Inbred C57BL, Regeneration, Cholangitis, Sclerosing, Cellular Senescence, Mice, Knockout, Hepatocytes, Mice, Proto-Oncogene Proteins c-mdm2, Keratin-19, Transforming Growth Factor beta1, Myofibroblasts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review